Since P72wt of p53 is the most commonly expressed phenotype in cancer and correlated with p38 MAPK/HSP27/CREB signaling, targeting of P72wt of p53 by an appropriate therapeutic agent may be a means of controlling the tumor progression. This evidence concerns the gene CREB1 and cancer.